M
Miroslav Milicevic
Researcher at University of Belgrade
Publications - 48
Citations - 2463
Miroslav Milicevic is an academic researcher from University of Belgrade. The author has contributed to research in topics: Hernia & Cancer. The author has an hindex of 17, co-authored 48 publications receiving 2072 citations.
Papers
More filters
Journal ArticleDOI
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).
Maximilian Bockhorn,Faik G. Uzunoglu,Mustapha Adham,Clem W. Imrie,Miroslav Milicevic,Aken A. Sandberg,Horacio J. Asbun,Claudio Bassi,Markus W. Büchler,Richard Charnley,Kevin C. Conlon,Laureano Fernandez Cruz,Christos Dervenis,Abe Fingerhutt,Helmut Friess,Dirk J. Gouma,Werner Hartwig,Keith D. Lillemoe,Marco Montorsi,John P. Neoptolemos,Shailesh V. Shrikhande,Kyoichi Takaori,William Traverso,Yogesh K. Vashist,Charles M. Vollmer,Charles J. Yeo,Jakob R. Izbicki +26 more
TL;DR: Current evidence justifies portomesenteric venous resection in patients with BRPC, and a new classification of extrahepatic mesentericoportal ven Mous resections is proposed by the ISGPS.
Journal ArticleDOI
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).
Johanna A. M. G. Tol,Dirk J. Gouma,Claudio Bassi,Christos Dervenis,Marco Montorsi,Mustapha Adham,Åke Andrén-Sandberg,Horacio J. Asbun,Maximilian Bockhorn,Markus W. Büchler,Kevin C. Conlon,Laureano Fernández-Cruz,Abe Fingerhut,Abe Fingerhut,Helmut Friess,Werner Hartwig,Jakob R. Izbicki,Keith D. Lillemoe,Miroslav Milicevic,John P. Neoptolemos,Shailesh V. Shrikhande,Charles M. Vollmer,Charles J. Yeo,Richard Charnley +23 more
TL;DR: Standard lymphadenectomy for pancreatoduodenectomy should strive to resect Ln stations no. 5, 6, 8a, 12b1,12b2, 12c, 13a, 13b, 14a, 14b, 17a, and 17b, for cancers of the body and tail of the pancreas, removal of stations 10, 11, and 18 is standard.
Journal ArticleDOI
Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS).
Werner Hartwig,Charles M. Vollmer,Abe Fingerhut,Charles J. Yeo,John P. Neoptolemos,Mustapha Adham,Åke Andrén-Sandberg,Horacio J. Asbun,Claudio Bassi,Max Bockhorn,Richard Charnley,Kevin C. Conlon,Christos Dervenis,Laureano Fernández-Cruz,Helmut Friess,Dirk J. Gouma,Clem W. Imrie,Keith D. Lillemoe,Miroslav Milicevic,Marco Montorsi,Shailesh V. Shrikhande,Yogesh K. Vashist,Jakob R. Izbicki,Markus W. Büchler +23 more
TL;DR: In this article, an international panel of pancreatic surgeons working in well-known, high-volume centers reviewed the literature on extended pancreatectomies and worked together to establish a consensus on the definition and the role of extended pancreatic cancer.
Journal ArticleDOI
Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.
Madhava Pai,Dimitris Zacharoulis,Miroslav Milicevic,Salah Helmy,Long R. Jiao,Nataša Levičar,Paul Tait,Michael S. Scott,Stephen B. Marley,Kevin Jestice,Maria Glibetic,Devinder S. Bansi,Shahid A. Khan,Despina Kyriakou,Christos Rountas,Andrew V. Thillainayagam,Joanna Nicholls,Steen Lindkaer Jensen,Jane F. Apperley,Myrtle Y. Gordon,Nagy A. Habib +20 more
TL;DR: It is safe to mobilize, expand, and reinfuse autologous CD34+ cells in patients with ALC and the clinical and biochemical improvement in the study group is encouraging and warrants further clinical trials.
Journal ArticleDOI
Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival.
Wilfried Tröger,Danijel Galun,Marcus Reif,Agnes Schumann,Nikola Stankovic,Miroslav Milicevic +5 more
TL;DR: The study findings suggest VaL to be a non-toxic and effective second-line therapy that offers a prolongation of OS as well as less disease-related symptoms for patients with locally advanced or metastatic pancreatic cancer.